Angle Share Price (AGL)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Angle Plc	LSE:AGL	London	Ordinary Share	GB0034330679	ORD 10P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+1.00p	+1.48%	68.50p	129,466	15:04:19

Bid Price		Offer Price	High Price	Low Price	Open Price
67.00p		70.00p	68.50p	67.00p	67.50p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Support Services	0.63	-8.93	-10.09		98.3

Related Shares
Experian (EXPN), Ferguson (FERG), Phsc (PHSC), Nakama (NAK)

Angle (AGL) Latest News

Angle News

Date	Time	Source	Headline
26/4/2019	12:29	ALNC	Angle's Parsortix System Used In Further "Groundbreaking" Research
26/4/2019	07:01	UKREG	Angle PLC IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
18/4/2019	11:35	ALNC	US Cancer Centre Uses Angle's Parsortix System For Assessments
18/4/2019	07:19	ALNC	*Angle Says Parsortix Used To Develop New Technique For Assessing Cancer
18/4/2019	07:00	RNSNON	Angle PLC Parsortix used in new cancer assessment technique
12/4/2019	11:59	ALNC	University Of Athens Cancer Study To Use Angle's Parsortix System
12/4/2019	07:00	RNSNON	Angle PLC LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04/4/2019	07:01	UKREG	Angle PLC AACR 2019
07/3/2019	13:09	ALNC	Angle Enrols All 400 Patients In US Breast Cancer Study For Parsortix
07/3/2019	07:01	UKREG	Angle PLC ENROLMENT COMPLETE FOR FDA CLINICAL STUDY

More Angle News

Angle Takeover Rumours

Angle (AGL) Share Charts

1 Year Angle Chart

1 Month Angle Chart

Intraday Angle Chart

Angle (AGL) Discussions and Chat

Angle Forums and Chat

Date	Time	Title	Posts
20/5/2019	11:33	ANGLE PLC - 2019 THREAD - LIQUID BIOPSY COMPANY	659
28/2/2019	12:22	ANGLE 2016 – LIQUID BIOPSY TAKEOVER TARGET	11,356
28/8/2018	12:29	ANGLE plc (AGL) One to Watch	-
02/7/2018	12:06	Still time to look at Angle (AGL)	-
14/5/2018	09:44	ANGLE (AGL) Strategic Move	-

Add a New Thread

Angle (AGL) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2019-05-21 15:15:46	67.40	35,000	23,590.00	O
2019-05-21 15:15:42	67.40	25,000	16,850.00	O
2019-05-21 14:48:35	67.40	25,000	16,850.00	O
2019-05-21 13:14:59	67.43	1,475	994.52	O
2019-05-21 12:11:21	67.45	5,000	3,372.50	O

View all Angle trades in real-time

Angle (AGL) Top Chat Posts

Date	Subject
21/5/2019 09:20	Angle Daily Update: Angle Plc is listed in the Support Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 67.50p. Angle Plc has a 4 week average price of 66.50p and a 12 week average price of 51.50p. The 1 year high share price is 78.50p while the 1 year low share price is currently 38p. There are currently 143,486,522 shares in issue and the average daily traded volume is 112,062 shares. The market capitalisation of Angle Plc is £98,288,267.57. Read Full Thread Reply
06/5/2019 15:59	alloa2003: I think the AGL share price is starting to reflect the potential value based on the risk that it may or may not be realised. For example if the potential value was £2 a share (based on profit, pe ratio, etc) and the chance of being successful was deemed 80% then you would expect the price to be much closer to £2. It is a form of arbitration with the share price reflecting the risk/reward factor compared to potential "fair value". Read Full Thread Follow Reply
23/4/2019 00:58	l0ngterm: Next two:2) What share price spectrum might arise if the trial demonstrates commercial data? I would hazard a guess anything between 200-500. However as Guardant is essentially data mining, and using analytics, and this seems to me where the long term value for Guardant is then.. what would a company pay to do the same with an approved front end CTC capture and harvest system? Possible over simplified this.. but you get my point.3) What share price spectrum might arise if the trial does not demonstrate commercial data?Depends on the data, if it proves CTCs can be captured, by the system and they then prove harvesting then what are the applications, especially if simulations, tests can be executed against cells going forward. We have had 19 papers expressing this so far.. this could actually be still be very lucrative. Just not immediately hazard a guess of say what 40p.. But all this also may be knocked sideways as essentially they are running the ovarian trial, if that is successful and proceeds to 200 patients then surely we will know sooner rather than later. Read Full Thread Follow Reply
22/4/2019 23:29	sicilian_kan: If the MBC trial is not, on the existing data (however confident one is) a nailed on certainty, surely the next questions are: 1) What is the best estimate probability of commercial data appearing in the MBC trial? 2) What share price spectrum might arise if the trial demonstrates commercial data? 3) What share price spectrum might arise if the trial does not demonstrate commercial data? Then an investment strategy can be formulated. There is far too little analysis of the actual MBC data that is available. There is also far too little analysis on here of the chance of success and on the share price gains and falls that might occur upon the MBC trial data being released. Read Full Thread Follow Reply
18/4/2019 09:00	alloa2003: There has been a sea change in the AGL share price of late, no highs then sharp reversals on announcements and no drifting on a lack of news. There is strong underlying demand for the shares which leads me to believe things are afoot behind the scenes. Read Full Thread Follow Reply
10/4/2019 09:46	sicilian_kan: At 70p, AGL's fully diluted market cap is £126m. 143,486,522 shares in issue, plus 20,555,806 options etc. = 164,042,328 shares fully diluted. This might see a 75p top before news, but quite frankly, the current share price is way overvalued given the risk involved, the laborious process involved (see youtube video) and the likely revenues from MBC. Given the hype around AGL, I think on good news 100-150p could be hit. On bad MBC results, we are looking at 10p-35p depending on how bad the results are. Results could also be mixed. So short term upside of 50-100%, short term downside potential of 50-80%. Chance of success, say 80-85%? I bear in mind that the ovarian trial was disappointing relative to the earlier study results. With significant downside possibility, I would expect a risk reward ratio of at least 3:1 to make this attractive. Fair price circa 50-55p? For those in at that level, it is definitely worth a hold, but I do not see buying in at the current share price as being in any way attractive. Read Full Thread Follow Reply
09/4/2019 16:46	jelenko: Probably an ISA scramble in my view. Given that news can come at any time on a few different fronts it makes sense to get the ISA loaded now, if funds allow. No doubt last weeks AACR will have raised the profile in the U.S. and that can only be good. I am holding these based on my own view that FDA is likely granted by end CY 2019 and if that is the case I feel the share price will at least treble from today's price. Not a bad return over a 9 month period. I plan to accumulate as many as I can on any weakness and just to provide occasional reassurance I keep tabs on EXAS share price on Nazdaq!! Read Full Thread Follow Reply
29/1/2019 10:20	semper vigilans: As usual a decent bit of research from a large, highly reputable organisation working in the right field, is not really recognised by the market. Whatever one thinks of false starts earlier, at some stage the build up of published, independent research must give the AGL share price a decent, upward shove? Read Full Thread Follow Reply
06/12/2018 10:46	alloa2003: Brexit is not helping sentiment but not the reason for AGL share price weakness. There is literally no interest in the stock at the moment - going to be news driven for some time to come until we see sales and profits. Might drift until it finds support. Read Full Thread Follow Reply
26/3/2018 09:17	alloa2003: I think AGL share price suffers from boredom at times between announcements. Very news driven as profitability is some way off. Read Full Thread Follow Reply
24/12/2017 11:06	alloa2003: Its that time of year - what are your predicitons for the AGL share price in 12 months? I will start at £2 a share :) Read Full Thread Follow Reply

Angle share price data is direct from the London Stock Exchange

Your Recent History

LSE

AGL

Angle

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190522 05:44:25